Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04725994
Title Study to Assess the Safety, Tolerability, and Efficacy of IDX-1197 in Combination With XELOX or Irinotecan in Patients With Advanced Gastric Cancer
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Idience Co., Ltd.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
USC Norris Comp. Cancer Ctr Hospital RECRUITING Los Angeles California 90033 United States Details
Hematology Oncology Clinic Baton Rouge / Sarah Cannon NOT_YET_RECRUITING Baton Rouge Louisiana 70809 United States Details
Dana Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Astera Cancer Care RECRUITING East Brunswick New Jersey 08816 United States Details
Beijing Cancer Hospital NOT_YET_RECRUITING Beijing China Details
The Sixth Affiliated Hospital of Sun Yat-Sen University NOT_YET_RECRUITING Guangzhou China Details
Shanghai East Hospital NOT_YET_RECRUITING Shanghai China Details
Dong-A University Hospital NOT_YET_RECRUITING Busan 49201 Korea, Republic of Details
Seoul National University Bundang Hospital RECRUITING Seongnam Korea, Republic of Details
Korea University Anam Hospital RECRUITING Seoul 02841 Korea, Republic of Details
Asan Medical Center RECRUITING Seoul Korea, Republic of Details
Samsung Medical Center RECRUITING Seoul Korea, Republic of Details
Seoul National University Hospital RECRUITING Seoul Korea, Republic of Details
Severance Hospital - Yonsei Cancer Center RECRUITING Seoul Korea, Republic of Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field